Biology Reference
In-Depth Information
Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, van Lunzen J, Antunes
F, Phillips AN, Lundgren JD, and the EuroSIDA group. 1999. Relations among CD4 lympho-
cyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the Euro-
SIDA Study. Ann Intern Med 130: 570±577.
Mollet L, Li TS, Samri A, Tournay C, Tubiana R, The Restim and Comet Study Groups, Calvez V,
Debre P, Katlama C, Autran B. 2000. Dynamics of HIV-speci®c CD8
T lymphocytes with
changes in viral load. J Immunol 165: 1692±1704.
Morris L, Binley JM, Clas BA, Bonhoe¨er S, Astill TP, Kost R, Hurley A, Cao Y, Markowitz M,
Ho DD, Moore JP. 1998. HIV-1 antigen-speci®c and -nonspeci®c B cell responses are sensitive
to combination antiretroviral therapy. J Exp Med 188: 233±245.
Neumann AU, Tubiana R, Calvez V, Robert C, Li TS, Agut H, Autran B, Katlama C and the
Comet study group. 1999. HIV-1 rebound during interruption of HAART has no deleterious
e¨ect on reinitiated treatment. AIDS 13: 677±683.
Ogg GS, Jin X, Bonhoe¨er S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones
SI, Hurley A, Markowitz M, Ho DD, McMichael AJ, Nixon DF. 1999. Decay kinetics of
human immunode®ciency virus-speci®c e¨ector cytotoxic T lymphocytes after combination
antiretroviral therapy. J Virol 73: 797±800.
Orendi JM, Bloem AC, Borle¨s JC, Wijnholds FJ, de Vos NM, Nottet HS, Visser MR, Snippe H,
Verhoef J, Boucher CA. 1998. Activation and cell cycle antigens in CD4
and CD8
T cells
correlate with plasma human immunode®ciency virus (HIV-1) RNA level in HIV-1 infection. J
Infect Dis 178: 1279±1287.
Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoe¨er S, Kuebler PJ, Donahoe SM,
Demoitie MA, Kakimoto WM, Ketas T, Clas B, Heymann JJ, Zhang L, Cao Y, Hurley A,
Moore JP, Ho DD, Markowitz M. 1999. HIV-1-speci®c immune responses in subjects who
temporarily contain virus replication after discontinuation of highly active antiretroviral ther-
apy. J Clin Invest 104: R13±R18.
Pakker NG, Notermans DW, De Boer RJ, Roos MTL, De Wolf F, Hill A, Leonard JM, Danner
SA, Miedema F, Schellekens PTA. 1998. Biphasic kinetics of peripheral blood T cells after triple
combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat
Med 2: 208±214.
Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ,
Holmberg SD and the HIV Outpatient Study Investigators. 1998. Declining morbidity and
mortality among patients with advanced human immunode®ciency virus infection. N Engl J
Med 338: 853±860.
Patki AH, Purvis SF, Valdez H, Spritzler J, Connick E, Kuritzkes DR, Kessler H, Fox L, St Clair
M, Landay A, Lederman MM. 1999. HIV infection perturbs DNA content of lymphoid cells:
partial correction after `suppression' of virus replication. AIDS 13: 1177±1185.
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo:
Virion clearance rate, infected cell life-span, and viral generation time. Science 387: 188±191.
Picker LJ, Treer JR, Ferguson DB, Collins PA, Buck D, Terstappen LW. 1993. Control of lymphocyte
recirculation in man. I. Di¨erential regulation of the peripheral lymph node homing receptor l-
selection on T cells during the virgin to memory cell transition. J Immunol 150: 1105±1121.
Piketty C, Castiel P, Belec L, Batisse D, Mohamed AS, Gilquin J, Gonzales-Canali G, Karmoch-
kine M, Weiss L, Aboulker JP, Kazatchkine MD. 1998. Discrepant responses to triple combi-
nation antiretroviral therapy in advanced HIV disease. AIDS 12: 745±750.
Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ. 1999. HIV-
speci®c CD4
T cells are detectable in most individuals with active HIV-1 infection, but decline
with prolonged viral suppression. Nat Med 5: 518±525.
Plana M, Garcia F, Gallart T, Miro JM, Gatell JM. 1998. Lack of T-cell proliferative response to
HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease.
Immunology Study Group of Spanish EARTH-1 Study [letter]. Lancet 352: 1194±1195.
